Table 2 Prevalence of eye diseases as reported by patients
Alla | Type 1 | Type 2 | ||
|---|---|---|---|---|
(n = 323) | (n = 44) | (n = 269) | ||
% | [CI 95%] | % | % | |
Eye diseases b (n = 318) | (n = 318) | (n = 44) | (n = 265) | |
Diabetic retinopathy | 14.2% | [10.3%–18.0%] | 40.9% | 9.8% |
Cataract | 35.8% | [30.5%–41.1%] | 40.9% | 35.1% |
Glaucoma | 12.6% | [8.9%–16.2%] | 11.4% | 12.8% |
Age-related macular degeneration | 4.7% | [2.4%–7.1%] | 4.5% | 4.5% |
Myopia, hyperopia, astigmatism, presbyopia | 36.2% | [30.9%–41.5%] | 38.6% | 35.5% |
Other | 2.8% | [1.0%–4.7%] | 2.3% | 3.0% |
No | 26.7% | [21.8%–31.6%] | 22.7% | 27.9% |
Do not know | 2.5% | [0.8%–4.2%] | 2.3% | 2.6% |
Number of eye diseases reported (n = 310) | (n = 310) | (n = 43) | (n = 258) | |
0 disease | 27.4% | - | 23.3% | 28.7% |
1 disease | 45.8% | - | 37.2% | 46.5% |
2 diseases | 20.0% | - | 18.6% | 20.2% |
≥ 3 diseases | 6.8% | - | 20.9% | 4.7% |
Treatment for diabetic retinopathy (among patients reporting diabetic retinopathy) b (n = 41) | n = 41) | n = 15) | (n = 25) | |
Laser therapy | 75.6% | [61.9%–89.3%] | 100.0% | 60.0% |
Eye injection | 26.8% | [12.7%–41.0%] | 33.3% | 24.0% |
Surgical intervention | 19.5% | [6.8%–32.2%] | 26.7% | 16.0% |
Other | 2.4% | [−2.5%–7.4%] | 0.0% | 4.0% |
Retinopathy without having had treatment | 9.8% | [0.3%–19.2%] | 0.0% | 16.0% |
Do not know | 2.4% | [−2.5%–7.4%] | 0.0% | 4.0% |